Compound teriflunomide transdermal patch for treating rheumatic arthritis, and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENYANG PHARMA UNIVERSITY
- Publication Date
- 2014-01-22
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to a compound teriflunomide transdermal patch for treating rheumatoid arthritis and a preparation method thereof, belonging to the technical field of medicine. Background technique
[0002] Rheumatoid arthritis is a long-term chronic inflammation caused by an autoimmune disorder that causes the immune system to attack the joints. The disease is prone to occur in small joints such as hands, wrists, and feet, and recurs in a symmetrical distribution. This inflammation can cause irreversible joint damage to disability, and can lead to joint degenerative changes due to joint pain and wear, so it is considered a locally aggressive tumor. Epidemiological studies have shown that the prevalence of rheumatoid arthritis is about 0.28%, and it gradually increases with age. The prevalence of middle-aged and elderly people over 46 years old is the highest, and the prevalence of women is 6 times that of men. . In my country, the prevalence o...